Approval by the U.S. Food and Drug Administration (FDA) of a procedure described as a “game changer” by physicians – transcatheter aortic valve replacement – now allows cardiac specialists at Barnes-Jewish to perform open-heart surgery without the “open” for patients previously unable to have surgery.